Dusseldorf - Delayed Quote EUR

Anavex Life Sciences Corp (12X1.DU)

7.68
+0.28
+(3.84%)
At close: May 8 at 7:30:19 PM GMT+2
Loading Chart for 12X1.DU
  • Previous Close 7.39
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 13.34
  • Volume 0
  • Avg. Volume 16
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 13, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 12X1.DU

View More

Performance Overview: 12X1.DU

Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

12X1.DU
35.06%
S&P 500 (^GSPC)
3.70%

1-Year Return

12X1.DU
127.24%
S&P 500 (^GSPC)
9.18%

3-Year Return

12X1.DU
5.13%
S&P 500 (^GSPC)
37.36%

5-Year Return

12X1.DU
62.37%
S&P 500 (^GSPC)
93.32%

Compare To: 12X1.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 12X1.DU

View More

Valuation Measures

As of 5/7/2025
  • Market Cap

    636.03M

  • Enterprise Value

    529.54M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    6.43

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 12X1.DU

View More